Contact lens companies have been working together to create price floors for their products, prohibiting retailers from offering competitive discounts and removing consumers’ ability to shop around for savings. Legislators in Utah recently passed a bill that would outlaw this practice but in May a federal appeals court temporarily blocked it from being enacted. But on Friday, the court vacated that injunction, allowing the new law to move forward. [More]
In recent years, many of the country’s biggest contact lens manufacturers moved to set minimum sale prices for their products, meaning any retailer wishing to discount these lenses couldn’t go below that price floor. The practice — which would have been illegal until a 2007 Supreme Court ruling — has come under scrutiny from federal lawmakers, and Utah state legislators passed a bill earlier this year that would outlaw this form of price-fixing in the state. However, a federal appeals court has temporarily sided with the lens makers and blocked that law from being enforced. [More]
I just got back from a long-overdue visit to the local vision-correction emporium, where I learned that for all these years, I’ve been fumbling through life only able to see 480 lines of resolution through my contact lenses. But now there are HD contact lenses. Bausch & Lomb’s PureVision2 HD lenses have been out for some time now, and I’m just learning about this upgrade to reality now. [More]
A Bausch & Lomb plant in South Carolina has cleared inspection after failing last year in an investigation following an outbreak of a rare and dangerous eye infection caused by its MoistureLoc contact solution.
Symptoms for Fungal keratitis include:
Here’s an eyewitness account of a user of the infamous Bausch & Lomb Renu Moisture Loc contact lens solution. She went blind in one eye. From the NYT:
Baush & Lomb, scraping the craggy fungal barnacle crust from its eyes, announced today it will permanently pull from the worldwide markets its MoistureLoc contact lens solution linked to a rare eye fungus. Shares rose nearly 9%.
Fungus is even more so among us.